Pulmonary Disease, Chronic Obstructive Clinical Trial
Official title:
Effects of Aerobic Interval Training on Cardiac Function, With Special Focus on Pulmonary Pressures and Right Sided Function, in Patients With Chronic Obstructive Pulmonary Disease and Hypoxemia
Verified date | January 2020 |
Source | Norwegian University of Science and Technology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Patients with severe Chronic Obstructive Pulmonary Disease (COPD) and low oxygen levels in
the blood are at risk of developing pulmonary hypertension and strain on the right side of
the heart, both of which are known to increase symptoms and worsen prognosis It is not fully
established whether interval exercise training in patients with severe COPD and concomitant
low oxygen levels is beneficial.
This study aims to evaluate the effects of aerobic interval exercise training in patients
with severe COPD and low oxygen levels in the blood, with a particular emphasis on such
effects on the cardiovascular system and pulmonary circulation.
Status | Completed |
Enrollment | 16 |
Est. completion date | December 31, 2019 |
Est. primary completion date | December 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 45 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Chronic Obstructive Pulmonary Disease (COPD) - Forced Expiratory Volume 1 second (FEV1) <60% of predicted - FEV1%FVC <70 % of predicted (FVC = Forced Vital Capacity) - Qualify for Long term oxygen therapy (LTOT), or presence of significant desaturation on exercise. Exclusion Criteria: - Unstable ischaemic heart disease or valvular heart disease. - Active malignant disease. - Substance abuse. - Physical or mental disability that prevents participation in the exercise programme or testing. - Pregnancy. - Exacerbation of COPD or respiratory tract infection last 6 weeks before. - Completed pulmonary rehabilitation programme or other organised exercise programme last 3 month - Use of high doses of systemic steroids. |
Country | Name | City | State |
---|---|---|---|
Norway | St Olavs Hospital, Lungemedisinsk Avdeling & Hjertemedisinsk Avdeling | Trondheim |
Lead Sponsor | Collaborator |
---|---|
Norwegian University of Science and Technology | St. Olavs Hospital |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Cardiac function | assessed by echocardiography | Change from baseline at 10 weeks | |
Other | Cardiac function | assessed by right heart catheterisation | Change from baseline at 10 weeks | |
Other | Respiratory function | assessed by spirometry | Change from baseline at 10 weeks | |
Other | Respiratory function | assessed by diffusion capacity, | Change from baseline at 10 weeks | |
Other | Respiratory function | assessed by arterial blood gas | Change from baseline at 10 weeks | |
Other | Functional capacity | assessed by shuttle walk test | Change from baseline at 10 weeks | |
Other | Functional capacity | assessed by 6 minute walk test | Change from baseline at 10 weeks | |
Other | Symptoms | COPD Assessment Test (CAT) | Change from baseline at 10 weeks | |
Other | Quality of life | St George Respiratory Questionnaire (SGRQ) | Change from baseline at 10 weeks | |
Primary | Pulmonary artery pressure | Examined by right heart catheterisation | Change from baseline at 10 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|